
AIFMD: High price for investor security?

The AIFM Directive continues to spark debate amongst industry practitioners, even as it is being implemented across Europe. While the new regulations will lower risk levels for smaller investors, GPs are concerned about a possible cost explosion. Diana Petrowicz reports
Up until now, private equity has been a largely unregulated sector. However, with the introduction of the AIFM Directive, which came into force on the 21st July 2011, EU countries now have just two years to apply the regulation to their national legislation.
Many industry professionals are unsure about the overall impact the directive will have, even at this late stage. Ralph Guenther, principal at Pantheon is positive about some aspects of the AIFMD as it will provide a minimum requirement regarding personal qualifications for fund managers. "At the moment everyone can call themselves fund manager and launch a fund, which does not make much sense to me," he says.
That fund managers will have to meet certain standards in order to operate should provide greater protection small investors who may not have the same capacity as larger LPs to track fund manager performance and quality. It could also help open up retail investment in listed private equity funds, by bolstering public confidence in the asset class.
However, less risk for the end investor will likely mean higher costs for GPs. In order to meet the AIFMD's requirements, GPs will face increased legal costs. This will particularly affect smaller houses, as larger PE outfits usually already have their own in-house legal department. "A smaller competitor on the market might have to employ additional staff such as a compliance or risk manager," Guenther points out.
Aside from rising costs, the new regulation will also increase the level of bureaucracy for private equity funds. Concerns are that GP's might need to raise fees in order to cope with the increased cost of compliance. This cost burden comes at a time when GPs are already struggling in a difficult fundraising climate and there is the shadow of further regulation to come, such as Basel III and Solvency II, both of which could have a significant impact on LPs appetite, meaning GPs will be reluctant to hike fees further.
GPs are in two minds regarding the AIFMD. While increased regulation will have a positive effect on the industry's image and investor confidence, the squeeze on costs could be detrimental for many smaller operators. "Looking at AIFMD, I believe that the impact of the directive will be relatively minor for a well-led fund management team which already operates under its own set of guidelines," Guenther concludes.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater